PROACT, a mobile application designed to facilitate patient participation in early clinical trials | Dr Hendrik-Tobias Arkenau at ECC 2015

PROACT, a mobile application designed to facilitate patient participation in early clinical trials | Dr Hendrik-Tobias Arkenau at ECC 2015

EMJ

4 years
847 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient Reported Opinions about Clinical Tolerability (PROACT), a mobile platform designed to enable patients to directly contribute to the understanding of investigational agents in early clinical development. European Medical Journal Website: http://emjreviews.com/ Twitter: https://twitter.com/EMJReviews Facebook: https://www.facebook.com/emjreviews
Up Next Autoplay